The Current Ratio as of December 2024 (TTM) for BioNTech SE (BNTX) is 7.33

According to BioNTech SE’s latest financial reports and current stock price. The company's current Current Ratio is 7.33. This represents a change of -17.83% compared to the average of 8.92 of the last 4 quarters.

BioNTech SE (BNTX) Historical Current Ratio (quarterly & annually)

How has BNTX Current Ratio performed in the past?

The mean historical Current Ratio of BioNTech SE over the last ten years is 4.80. The current 7.33 Current Ratio has changed 15.18% with respect to the historical average. Over the past ten years (40 quarters), BNTX's Current Ratio was at its highest in in the March 2023 quarter at 12.95. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

BioNTech SE (BNTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BioNTech SE Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioNTech SE (BNTX) Average Current Ratio

How has BNTX Current Ratio performed in the past?

The current Current Ratio of BioNTech SE (BNTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioNTech SE (BNTX) Current Ratio vs. Peers

How is BNTX’s Current Ratio compared to its peers?

BioNTech SE’s Current Ratio is greater than Novavax, Inc. (0.93), less than CohBar, Inc. (15.69), greater than Ginkgo Bioworks Holdings, Inc. (5.79), less than CRISPR Therapeutics AG (21.64), less than Ocean Biomedical, Inc. (0), greater than Enveric Biosciences, Inc. (0.07), greater than Hepion Pharmaceuticals, Inc. (5.17), greater than Elevation Oncology, Inc. (1.30), less than AVROBIO, Inc. (17.77), less than PTC Therapeutics, Inc. (26.17), greater than Krystal Biotech, Inc. (2.10), less than Sarepta Therapeutics, Inc. (7.97), greater than Iovance Biotherapeutics, Inc. (3.84), greater than Madrigal Pharmaceuticals, Inc. (4.22), greater than null (5.98),

Build a custom stock screener for BioNTech SE (BNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioNTech SE (BNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.